| Code | Description | Claims | Beneficiaries | Total Paid |
| 8888888 |
Internal/system code - not a standard HCPCS code |
70,594 |
29,716 |
$31.67M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
38,211 |
30,362 |
$1.38M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,212 |
12,304 |
$813K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,946 |
15,731 |
$722K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,855 |
3,961 |
$554K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,659 |
18,558 |
$529K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,092 |
11,110 |
$457K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,589 |
3,279 |
$454K |
| 80050 |
General health panel |
4,602 |
4,197 |
$416K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,335 |
1,248 |
$270K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,725 |
4,186 |
$251K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,402 |
5,109 |
$229K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,167 |
14,264 |
$186K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,869 |
1,979 |
$178K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,413 |
1,360 |
$177K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,487 |
860 |
$175K |
| J2704 |
Injection, propofol, 10 mg |
10,741 |
9,072 |
$163K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
9,003 |
6,628 |
$160K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,144 |
999 |
$152K |
| 85027 |
|
5,667 |
4,869 |
$151K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,111 |
3,664 |
$147K |
| 71046 |
Radiologic examination, chest; 2 views |
3,888 |
3,499 |
$144K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,965 |
8,993 |
$143K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,951 |
3,031 |
$134K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,849 |
3,507 |
$134K |
| 81025 |
|
3,239 |
2,958 |
$133K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,780 |
7,696 |
$132K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
786 |
725 |
$129K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,812 |
9,115 |
$129K |
| 81001 |
|
16,566 |
14,174 |
$114K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,081 |
987 |
$105K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
975 |
904 |
$101K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,624 |
4,942 |
$93K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,243 |
1,056 |
$90K |
| 80053 |
Comprehensive metabolic panel |
33,108 |
26,810 |
$87K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,561 |
2,335 |
$79K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
520 |
465 |
$78K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,851 |
4,609 |
$78K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,547 |
1,443 |
$76K |
| 74018 |
|
1,483 |
1,283 |
$74K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,292 |
1,995 |
$73K |
| 71045 |
Radiologic examination, chest; single view |
6,670 |
5,838 |
$71K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,635 |
5,066 |
$69K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
476 |
443 |
$69K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,153 |
1,046 |
$68K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,590 |
7,428 |
$67K |
| 59025 |
Fetal non-stress test |
3,148 |
1,178 |
$67K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,407 |
1,283 |
$64K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,756 |
1,575 |
$63K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,691 |
5,045 |
$58K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,342 |
4,770 |
$58K |
| 82947 |
|
1,385 |
1,230 |
$54K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,664 |
6,146 |
$54K |
| 73610 |
|
816 |
742 |
$52K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,314 |
9,589 |
$50K |
| 73630 |
|
1,060 |
952 |
$48K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,489 |
2,078 |
$48K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
183 |
165 |
$46K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,995 |
4,542 |
$46K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,668 |
6,565 |
$45K |
| 93325 |
|
596 |
558 |
$44K |
| 96376 |
|
3,460 |
2,919 |
$44K |
| 78431 |
|
103 |
90 |
$43K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
911 |
856 |
$41K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,934 |
5,289 |
$41K |
| 97602 |
|
699 |
433 |
$40K |
| 73562 |
|
852 |
771 |
$40K |
| 84703 |
|
5,655 |
5,066 |
$38K |
| J2785 |
Injection, regadenoson, 0.1 mg |
297 |
268 |
$38K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,704 |
4,509 |
$38K |
| 86901 |
|
2,676 |
2,336 |
$37K |
| 90686 |
|
1,722 |
1,583 |
$37K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,949 |
1,633 |
$35K |
| 82247 |
|
5,370 |
2,734 |
$33K |
| 73130 |
|
600 |
541 |
$33K |
| 76801 |
|
1,164 |
1,004 |
$31K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
883 |
683 |
$30K |
| 76770 |
|
503 |
452 |
$30K |
| J2060 |
Injection, lorazepam, 2 mg |
2,116 |
1,676 |
$30K |
| 87081 |
|
979 |
907 |
$27K |
| 87070 |
|
1,349 |
1,181 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,198 |
1,109 |
$26K |
| J3490 |
Unclassified drugs |
622 |
570 |
$25K |
| 84702 |
|
4,699 |
4,040 |
$25K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,271 |
1,116 |
$25K |
| C1769 |
Guide wire |
828 |
736 |
$24K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,364 |
1,155 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,404 |
3,138 |
$24K |
| 81003 |
|
1,825 |
1,608 |
$24K |
| 72141 |
|
169 |
158 |
$22K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,184 |
646 |
$22K |
| 86850 |
|
1,946 |
1,687 |
$21K |
| 93971 |
|
1,033 |
917 |
$21K |
| 84484 |
|
6,718 |
5,334 |
$20K |
| 76830 |
Ultrasound, transvaginal |
636 |
602 |
$20K |
| 73030 |
|
576 |
494 |
$19K |
| 0002A |
|
687 |
643 |
$19K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
323 |
291 |
$19K |
| 0001A |
|
683 |
656 |
$18K |
| 85651 |
|
2,774 |
2,312 |
$18K |
| 87186 |
|
2,552 |
2,234 |
$18K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,592 |
2,279 |
$18K |
| 73110 |
|
372 |
337 |
$18K |
| 95812 |
|
101 |
96 |
$18K |
| 87631 |
|
339 |
295 |
$18K |
| 97161 |
|
237 |
220 |
$17K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
314 |
289 |
$17K |
| J1630 |
Injection, haloperidol, up to 5 mg |
897 |
769 |
$16K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,748 |
1,577 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
408 |
362 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,638 |
2,176 |
$15K |
| 82565 |
|
974 |
887 |
$15K |
| 90723 |
|
743 |
629 |
$15K |
| 95811 |
|
31 |
27 |
$15K |
| 80061 |
Lipid panel |
3,180 |
2,959 |
$13K |
| 72100 |
|
312 |
282 |
$13K |
| 83690 |
|
9,379 |
7,961 |
$13K |
| 89060 |
|
308 |
266 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
103 |
90 |
$12K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
40 |
39 |
$12K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
485 |
441 |
$11K |
| 73140 |
|
120 |
107 |
$11K |
| 84439 |
|
2,587 |
2,365 |
$11K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,503 |
2,012 |
$11K |
| 90715 |
|
852 |
779 |
$10K |
| 88312 |
|
580 |
511 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,802 |
1,689 |
$10K |
| 76642 |
|
456 |
373 |
$10K |
| 86900 |
|
1,739 |
1,461 |
$10K |
| 93017 |
|
520 |
468 |
$10K |
| 90648 |
|
1,063 |
912 |
$9K |
| 83605 |
|
6,229 |
5,128 |
$9K |
| 88304 |
|
1,067 |
987 |
$9K |
| 85610 |
|
4,627 |
3,795 |
$9K |
| 76820 |
|
104 |
37 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,367 |
3,906 |
$7K |
| 94010 |
|
106 |
101 |
$7K |
| 86140 |
|
4,723 |
3,951 |
$7K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,644 |
1,485 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,727 |
1,355 |
$7K |
| 73590 |
|
169 |
151 |
$7K |
| 70486 |
|
194 |
171 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
602 |
578 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,824 |
2,440 |
$6K |
| 73090 |
|
186 |
162 |
$6K |
| 85730 |
|
1,458 |
1,271 |
$6K |
| 82805 |
|
519 |
418 |
$6K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
145 |
142 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
492 |
460 |
$6K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
438 |
398 |
$6K |
| 43235 |
|
98 |
88 |
$6K |
| 88307 |
|
200 |
177 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
495 |
463 |
$5K |
| 72170 |
|
97 |
84 |
$5K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
197 |
182 |
$5K |
| 73080 |
|
90 |
78 |
$5K |
| 85379 |
|
3,161 |
2,791 |
$5K |
| 94729 |
|
147 |
138 |
$4K |
| 12001 |
|
193 |
174 |
$4K |
| 87040 |
|
3,059 |
2,293 |
$4K |
| 93321 |
|
243 |
224 |
$4K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
91 |
90 |
$4K |
| 87077 |
|
934 |
798 |
$4K |
| 95806 |
|
59 |
50 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
92 |
89 |
$3K |
| 84100 |
|
1,474 |
1,104 |
$3K |
| 88342 |
|
142 |
128 |
$3K |
| 97162 |
|
30 |
28 |
$3K |
| 87075 |
|
380 |
342 |
$3K |
| 83735 |
|
2,677 |
2,071 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
391 |
339 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
54 |
40 |
$3K |
| 82728 |
|
1,098 |
995 |
$3K |
| 87088 |
|
2,030 |
1,798 |
$3K |
| 83880 |
|
1,573 |
1,342 |
$3K |
| 82550 |
|
567 |
469 |
$2K |
| 84132 |
|
1,130 |
974 |
$2K |
| 82731 |
|
67 |
63 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
503 |
388 |
$2K |
| 76870 |
|
43 |
38 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
916 |
834 |
$2K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
116 |
104 |
$2K |
| 0482T |
|
14 |
14 |
$2K |
| 76536 |
|
32 |
30 |
$2K |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$2K |
| 73502 |
|
89 |
82 |
$2K |
| 90633 |
|
49 |
44 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
111 |
81 |
$2K |
| 12011 |
|
132 |
122 |
$2K |
| 85007 |
|
1,543 |
1,300 |
$2K |
| 90670 |
|
1,067 |
908 |
$2K |
| 83516 |
|
151 |
141 |
$2K |
| J1790 |
Injection, droperidol, up to 5 mg |
161 |
146 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
390 |
364 |
$2K |
| 82570 |
|
1,258 |
1,019 |
$2K |
| 80069 |
|
159 |
137 |
$1K |
| 82248 |
|
434 |
283 |
$1K |
| 84481 |
|
51 |
50 |
$1K |
| 84156 |
|
862 |
659 |
$1K |
| 84466 |
|
425 |
393 |
$1K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
37 |
36 |
$1K |
| 72040 |
|
25 |
24 |
$1K |
| 0031A |
|
62 |
59 |
$1K |
| 91300 |
|
85 |
72 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
49 |
42 |
$991.32 |
| 86003 |
|
48 |
25 |
$946.33 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,867 |
1,635 |
$933.49 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26 |
25 |
$850.06 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
73 |
68 |
$844.90 |
| J1815 |
Injection, insulin, per 5 units |
457 |
274 |
$815.63 |
| 90474 |
|
529 |
441 |
$627.49 |
| 29125 |
|
24 |
24 |
$625.54 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,634 |
912 |
$623.47 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
591 |
524 |
$582.67 |
| 0450 |
Emergency room services |
13 |
12 |
$545.60 |
| 80164 |
|
303 |
274 |
$533.84 |
| 86769 |
|
12 |
12 |
$509.67 |
| 73560 |
|
16 |
12 |
$481.67 |
| 93226 |
|
27 |
27 |
$471.91 |
| 10060 |
|
15 |
13 |
$467.21 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
23 |
18 |
$424.67 |
| 82607 |
|
355 |
334 |
$413.72 |
| 47563 |
|
45 |
39 |
$413.01 |
| 90680 |
|
572 |
475 |
$393.08 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
65 |
62 |
$372.67 |
| 71250 |
|
13 |
12 |
$371.70 |
| 70491 |
|
12 |
12 |
$330.14 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
279 |
224 |
$304.12 |
| 0064A |
|
21 |
20 |
$260.35 |
| 88302 |
|
35 |
32 |
$254.65 |
| 85018 |
|
53 |
42 |
$227.95 |
| 84146 |
|
28 |
27 |
$226.88 |
| 82950 |
|
101 |
98 |
$221.45 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
73 |
69 |
$205.30 |
| 82784 |
|
107 |
87 |
$199.48 |
| 70496 |
|
158 |
147 |
$191.53 |
| 70498 |
|
149 |
134 |
$190.93 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
74 |
70 |
$184.82 |
| 83540 |
|
554 |
520 |
$180.69 |
| 83615 |
|
462 |
398 |
$163.86 |
| 80197 |
|
172 |
130 |
$152.00 |
| 90694 |
|
15 |
14 |
$144.62 |
| 82140 |
|
132 |
113 |
$123.54 |
| G0378 |
Hospital observation service, per hour |
325 |
288 |
$120.94 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
23 |
14 |
$109.32 |
| 72131 |
|
12 |
12 |
$109.32 |
| 83970 |
|
54 |
50 |
$87.90 |
| 87449 |
|
40 |
38 |
$86.76 |
| 74300 |
|
59 |
51 |
$54.71 |
| 80178 |
|
42 |
37 |
$49.83 |
| 88300 |
|
12 |
12 |
$45.00 |
| 86038 |
|
26 |
25 |
$39.41 |
| 36415 |
Collection of venous blood by venipuncture |
16 |
16 |
$37.56 |
| 87046 |
|
24 |
24 |
$35.24 |
| 84478 |
|
70 |
63 |
$26.48 |
| 84145 |
|
94 |
86 |
$25.91 |
| 87102 |
|
14 |
12 |
$21.83 |
| 80175 |
|
15 |
13 |
$17.68 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
13 |
12 |
$8.97 |
| 87340 |
|
33 |
29 |
$7.30 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
14 |
13 |
$0.00 |
| 87045 |
|
12 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
85 |
67 |
$0.00 |
| 93304 |
|
15 |
14 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
58 |
51 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
25 |
25 |
$0.00 |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
38 |
37 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
40 |
29 |
$0.00 |
| 96367 |
|
42 |
27 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
286 |
266 |
$0.00 |
| 82010 |
|
15 |
12 |
$0.00 |
| 78434 |
|
78 |
66 |
$0.00 |
| 76376 |
|
51 |
44 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
34 |
17 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
42 |
41 |
$0.00 |
| 77336 |
|
58 |
25 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
29 |
26 |
$0.00 |
| 96415 |
|
103 |
93 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
117 |
99 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
46 |
13 |
$0.00 |
| 77280 |
|
14 |
12 |
$0.00 |
| 78492 |
|
14 |
14 |
$0.00 |
| 74420 |
|
28 |
25 |
$0.00 |
| 36430 |
|
22 |
12 |
$0.00 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
35 |
35 |
$0.00 |
| 78499 |
|
14 |
14 |
$0.00 |
| 97165 |
|
13 |
13 |
$0.00 |
| 88341 |
|
13 |
12 |
$0.00 |